scholarly journals Structure of the staphylococcal enterotoxin B vaccine candidate S19 showing eliminated superantigen activity

Author(s):  
Woo Hyeon Jeong ◽  
Dong Hyun Song ◽  
Gyeung Haeng Hur ◽  
Seong Tae Jeong

Four mutations (N23A, Y90A, R110A and F177A) were introduced into S19, a vaccine candidate for staphylococcal enterotoxin B (SEB), resulting in a lower binding affinity towards the T-cell receptor beta chain (TCB) and reducing its superantigen activity. The structure of S19 was solved and was superposed on the native or complex structure of SEB. In the superposition model, mutations that were introduced seemed to reduce the number of hydrogen bonds at the SEB–TCB interface. S19 also displayed an unexpected structural change around the flexible-loop region owing to the Y90A mutation. This local structural change provided evidence that the mutated form of S19 could have a lower affinity for major histocompatibility complex (MHC) class II than wild-type SEB.

1992 ◽  
Vol 175 (2) ◽  
pp. 387-396 ◽  
Author(s):  
J W Kappler ◽  
A Herman ◽  
J Clements ◽  
P Marrack

Staphylococcal enterotoxin B (SEB) is both a superantigen and toxin. As a superantigen, SEB can bind to major histocompatibility complex (MHC) class II molecules to form a ligand for alpha/beta T cell receptors bearing particular V beta elements. As a toxin, SEB causes rapid weight loss in mice sometimes leading to death. We show here that both of these functions map to the NH2-terminal portion of the toxin. Three regions were identified: one important in MHC class II binding, one in T cell recognition, and one in both functions. These results support the conclusion that the toxicity of SEB is related to massive T cell stimulation and release of cytokine mediators and show that the residues interacting with MHC and the T cell receptor are intertwined.


2010 ◽  
Vol 23 (5) ◽  
pp. 415-421 ◽  
Author(s):  
Saeko Yanaka ◽  
Motonori Kudou ◽  
Yoshikazu Tanaka ◽  
Takumi Sasaki ◽  
Sumiyo Takemoto ◽  
...  

2019 ◽  
Vol 431 (21) ◽  
pp. 4354-4367 ◽  
Author(s):  
Gang Chen ◽  
Hatice Karauzum ◽  
Hua Long ◽  
Danielle Carranza ◽  
Frederick W. Holtsberg ◽  
...  

mAbs ◽  
2013 ◽  
Vol 6 (1) ◽  
pp. 119-129 ◽  
Author(s):  
Tian Xia ◽  
Shuaiyi Liang ◽  
Huajing Wang ◽  
Shi Hu ◽  
Yuna Sun ◽  
...  

1990 ◽  
Vol 171 (2) ◽  
pp. 455-464 ◽  
Author(s):  
P Marrack ◽  
M Blackman ◽  
E Kushnir ◽  
J Kappler

Staphylococcal enterotoxin B (SEB) has been shown in the past to be a potent T cell stimulant in mouse or man. The toxin acts as a superantigen that is, it binds to class II MHC proteins and, as such a complex, stimulates T cells bearing particular V beta s as part of their receptors. The toxin also has several pathological effects, causing, in mice, rapid weight loss, thymus atrophy, immunosuppression, and, at high doses, death. The data in this paper show that at least one of these effects, weight loss, is T cell mediated. Staphylococcal enterotoxin-mediated weight loss is MHC dependent, and is almost absent in animals expressing MHC class II molecules, which, complexed with SEB, are poor T cell stimulants. Also, mice that lack T cell function, genetically or because of cyclosporin A treatment, lose no or less weight than controls in response to SEB. Finally, animals bred such that they express few T cells bearing V beta s with which SEB can interact lose much less weight in response to the toxin than littermate controls that have higher numbers of reactive T cells. It is therefore suggested that the pathological effects of the staphylococcal, T cell-stimulating toxins in mouse and man may be partially or wholly the consequence of massive T cell stimulation.


Sign in / Sign up

Export Citation Format

Share Document